Anna Tervasmäki - Concepedia

Author

Anna Tervasmäki

University of Oulu ORCID

Also Known As

A. Tervasmäki, Anna Tervasmäki

Publications

220

Citations

H-Index

Concepts

All Affiliations

University of Oulu NordLab Oulu University Hospital University of Eastern Finland Kuopio University Hospital

About

Anna Tervasmäki is an author at University of Oulu specializing in cancer genetics, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	55
2	Pathology	2	2	42
3	Engineering	1	1	25
4	Cell Biology	1	1	13
5	Molecular Genetics	1	1	17

Anna Tervasmäki

Publications

193

Citations

H-Index

Page 1

	Year	Citations
FANCM mutation c.5791C>T is a risk factor for triple-negative breast cancer in the Finnish population Johanna I. Kiiski, Anna Tervasmäki, Liisa M. Pelttari, Breast Cancer Research and Treatment	2017	36
Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility Tuomo Mantere, Anna Tervasmäki, Anna Nurmi, Scientific Reports	2017	34
Exome sequencing identifies a recurrent variant in SERPINA3 associating with hereditary susceptibility to breast cancer Susanna Koivuluoma, Anna Tervasmäki, Saila Kauppila, European Journal of Cancer	2020	27
Recurrent CYP2C19 deletion allele is associated with triple-negative breast cancer Anna Tervasmäki, Robert Winqvist, Arja Jukkola‐Vuorinen, BMC Cancer	2014	25
Targeted Next-Generation Sequencing Identifies a Recurrent Mutation in MCPH1 Associating with Hereditary Breast Cancer Susceptibility Tuomo Mantere, Robert Winqvist, Saila Kauppila, PLoS Genetics Recurrent MutationBreast OncologyEngineeringGeneticsPathology	2016	25
Rare missense mutations in <i>RECQL</i> and <i>POLG</i> associate with inherited predisposition to breast cancer Anna Tervasmäki, Tuomo Mantere, Jaana M. Hartikainen, International Journal of Cancer Rare Missense MutationsAllelic VariantParallel SequencingGenetic DisorderGenetics	2018	17
<i>FANCM</i> c.5101C>T mutation associates with breast cancer survival and treatment outcome Johanna I. Kiiski, Rainer Fagerholm, Anna Tervasmäki, International Journal of Cancer	2016	16
Tumor suppressor MCPH1 regulates gene expression profiles related to malignant conversion and chromosomal assembly Anna Tervasmäki, Tuomo Mantere, Leila Eshraghi, International Journal of Cancer Breast OncologyKnown Susceptibility GenesCancer BiologyTumor BiologyMalignant Conversion	2019	13

Page 1